Location History:
- Germantown, MD (US) (1998)
- Gaithersburg, MD (US) (2000 - 2004)
- Atlanta, GA (US) (2006)
- Norcross, GA (US) (2002 - 2012)
Company Filing History:
Years Active: 1998-2012
Title: The Innovations of Charles A. Kunsch
Introduction
Charles A. Kunsch is a notable inventor based in Norcross, Georgia, with a remarkable portfolio of 17 patents. His work primarily focuses on advancements in biotechnology, particularly in the areas of polynucleotide sequences and cytoprotective response elements. Kunsch's inventions have significant implications for medical research and therapeutic applications.
Latest Patents
Among his latest patents, Kunsch has developed innovative polynucleotide sequences of the genome, which include polypeptide sequences encoded by these polynucleotides. His inventions also encompass vectors and hosts that utilize these polynucleotides, along with assays and various applications. Another significant patent addresses protection against oxidative stress and inflammation through a cytoprotective response element. This invention details regulatory DNA sequences that enhance the protective capabilities of cells against oxidative damage, particularly during conditions of hemodynamic shear stress.
Career Highlights
Kunsch has had a distinguished career, contributing to prominent companies such as Human Genome Sciences, Inc. and Atherogenics, Inc. His work in these organizations has furthered the understanding and application of genetic research in therapeutic contexts.
Collaborations
Throughout his career, Kunsch has collaborated with esteemed colleagues, including Craig A. Rosen and Gil H. Choi. These partnerships have fostered innovation and advancement in the field of biotechnology.
Conclusion
Charles A. Kunsch's contributions to biotechnology through his patents and collaborations highlight his significant role as an inventor. His work continues to influence the landscape of genetic research and therapeutic development.